SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-21-013342
Filing Date
2021-05-26
Accepted
2021-05-26 08:03:31
Documents
3
Period of Report
2021-05-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K snbp20210525_8k.htm 8-K 49903
2 EXHIBIT 99.1 ex_253219.htm EX-99.1 8465
3 p01.jpg GRAPHIC 7256
  Complete submission text file 0001437749-21-013342.txt   70020
Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387
Business Address 712 VISTA BLVD #305 WACONIA MN 55387 9524791196
Panbela Therapeutics, Inc. (Filer) CIK: 0001029125 (see all company filings)

IRS No.: 870543922 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39468 | Film No.: 21962765
SIC: 2834 Pharmaceutical Preparations